Cargando…
Angiographic features and transarterial embolization of retained placenta with abnormal vaginal bleeding
OBJECTIVES: To clarify characteristic angiographic features and clinical efficacy of selective transarterial embolization (TAE) of retained placenta with abnormal vaginal bleeding. METHODS: The study cohort comprised 22 patients (mean age, 33.5 years; range, 22–24 years) who underwent selective TAE...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563979/ https://www.ncbi.nlm.nih.gov/pubmed/34727271 http://dx.doi.org/10.1186/s42155-021-00265-z |
_version_ | 1784593517250609152 |
---|---|
author | Takaji, Ryo Kiyosue, Hiro Maruno, Miyuki Hongo, Norio Shimada, Ryuichi Ide, Satomi Tokuyama, Kohei Okamoto, Mamiko Kawano, Yasushi Asayama, Yoshiki |
author_facet | Takaji, Ryo Kiyosue, Hiro Maruno, Miyuki Hongo, Norio Shimada, Ryuichi Ide, Satomi Tokuyama, Kohei Okamoto, Mamiko Kawano, Yasushi Asayama, Yoshiki |
author_sort | Takaji, Ryo |
collection | PubMed |
description | OBJECTIVES: To clarify characteristic angiographic features and clinical efficacy of selective transarterial embolization (TAE) of retained placenta with abnormal vaginal bleeding. METHODS: The study cohort comprised 22 patients (mean age, 33.5 years; range, 22–24 years) who underwent selective TAE for retained placenta with abnormal bleeding between January 2018 and December 2020 at our institution. Angiographic images were reviewed by two certified radiologists with consensus. Medical records were reviewed to evaluate the efficacy of TAE. Angiographic features of retained placenta, technical success (disappearance of abnormal findings on angiography), complications, clinical outcomes (hemostatic effects and recurrent bleeding) were evaluated. RESULTS: Pelvic angiography showed a dilated vascular channel mimicking arteriovenous fistulas or an aneurysm contiguous with dilated uterine arteries in the mid-arterial–capillary phase in 20 patients; it showed contrast brush in the remaining two patients. TAE technical success was achieved in all patients. No major complications were observed in any patients. Fifteen patients were followed up with expectant management after TAE; all but one patient showed no re-bleeding during the follow-up period (mean follow-up interval, 3.4 months; range, 1–17 months). One patient showed minor rebleeding, which resolved spontaneously. Seven patients underwent scheduled hysteroscopic resection within 1 week after TAE, and no excessive bleeding was observed during or after the surgical procedure in all seven patients. CONCLUSIONS: The characteristic angiographic feature of retained placenta is “dilated vascular channel that mimic low flow AVM.” TAE is a safe and effective treatment to manage retained placenta with abnormal bleeding. |
format | Online Article Text |
id | pubmed-8563979 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-85639792021-11-15 Angiographic features and transarterial embolization of retained placenta with abnormal vaginal bleeding Takaji, Ryo Kiyosue, Hiro Maruno, Miyuki Hongo, Norio Shimada, Ryuichi Ide, Satomi Tokuyama, Kohei Okamoto, Mamiko Kawano, Yasushi Asayama, Yoshiki CVIR Endovasc Original Article OBJECTIVES: To clarify characteristic angiographic features and clinical efficacy of selective transarterial embolization (TAE) of retained placenta with abnormal vaginal bleeding. METHODS: The study cohort comprised 22 patients (mean age, 33.5 years; range, 22–24 years) who underwent selective TAE for retained placenta with abnormal bleeding between January 2018 and December 2020 at our institution. Angiographic images were reviewed by two certified radiologists with consensus. Medical records were reviewed to evaluate the efficacy of TAE. Angiographic features of retained placenta, technical success (disappearance of abnormal findings on angiography), complications, clinical outcomes (hemostatic effects and recurrent bleeding) were evaluated. RESULTS: Pelvic angiography showed a dilated vascular channel mimicking arteriovenous fistulas or an aneurysm contiguous with dilated uterine arteries in the mid-arterial–capillary phase in 20 patients; it showed contrast brush in the remaining two patients. TAE technical success was achieved in all patients. No major complications were observed in any patients. Fifteen patients were followed up with expectant management after TAE; all but one patient showed no re-bleeding during the follow-up period (mean follow-up interval, 3.4 months; range, 1–17 months). One patient showed minor rebleeding, which resolved spontaneously. Seven patients underwent scheduled hysteroscopic resection within 1 week after TAE, and no excessive bleeding was observed during or after the surgical procedure in all seven patients. CONCLUSIONS: The characteristic angiographic feature of retained placenta is “dilated vascular channel that mimic low flow AVM.” TAE is a safe and effective treatment to manage retained placenta with abnormal bleeding. Springer International Publishing 2021-11-02 /pmc/articles/PMC8563979/ /pubmed/34727271 http://dx.doi.org/10.1186/s42155-021-00265-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Takaji, Ryo Kiyosue, Hiro Maruno, Miyuki Hongo, Norio Shimada, Ryuichi Ide, Satomi Tokuyama, Kohei Okamoto, Mamiko Kawano, Yasushi Asayama, Yoshiki Angiographic features and transarterial embolization of retained placenta with abnormal vaginal bleeding |
title | Angiographic features and transarterial embolization of retained placenta with abnormal vaginal bleeding |
title_full | Angiographic features and transarterial embolization of retained placenta with abnormal vaginal bleeding |
title_fullStr | Angiographic features and transarterial embolization of retained placenta with abnormal vaginal bleeding |
title_full_unstemmed | Angiographic features and transarterial embolization of retained placenta with abnormal vaginal bleeding |
title_short | Angiographic features and transarterial embolization of retained placenta with abnormal vaginal bleeding |
title_sort | angiographic features and transarterial embolization of retained placenta with abnormal vaginal bleeding |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563979/ https://www.ncbi.nlm.nih.gov/pubmed/34727271 http://dx.doi.org/10.1186/s42155-021-00265-z |
work_keys_str_mv | AT takajiryo angiographicfeaturesandtransarterialembolizationofretainedplacentawithabnormalvaginalbleeding AT kiyosuehiro angiographicfeaturesandtransarterialembolizationofretainedplacentawithabnormalvaginalbleeding AT marunomiyuki angiographicfeaturesandtransarterialembolizationofretainedplacentawithabnormalvaginalbleeding AT hongonorio angiographicfeaturesandtransarterialembolizationofretainedplacentawithabnormalvaginalbleeding AT shimadaryuichi angiographicfeaturesandtransarterialembolizationofretainedplacentawithabnormalvaginalbleeding AT idesatomi angiographicfeaturesandtransarterialembolizationofretainedplacentawithabnormalvaginalbleeding AT tokuyamakohei angiographicfeaturesandtransarterialembolizationofretainedplacentawithabnormalvaginalbleeding AT okamotomamiko angiographicfeaturesandtransarterialembolizationofretainedplacentawithabnormalvaginalbleeding AT kawanoyasushi angiographicfeaturesandtransarterialembolizationofretainedplacentawithabnormalvaginalbleeding AT asayamayoshiki angiographicfeaturesandtransarterialembolizationofretainedplacentawithabnormalvaginalbleeding |